Tuesday, January 14, 2025

Innova Captab Limited Announces Commercialization of its Kathua, Jammu Facility


Innova Captab Limited, a leading integrated pharmaceutical company, is proud to announce the commencement of commercial production at its state-of-the-art manufacturing facility in Kathua, Jammu. 

The facility comprises four dedicated manufacturing blocks including General, Cephalosporin, Penicillin and Penum with a capability to manufacture a diverse range of products in oral solid dosages, dry powder injectables, dry syrup, BFS, large volume parenterals and respiratory respule products.

With this expansion, the company, at a consolidated level, have total five manufacturing facilities with nine independent manufacturing blocks. 

Commenting on the recent development, Mr. Vinay Lohariwala, Managing Director – Innova Captab Limited said “We are thrilled to announce the launch of commercial operations at our new Kathua, Jammu facility. This marks a significant milestone in our growth journey, enhancing both our production capacity and product basket. This will also enhance our ability to meet the evolving needs of our customers. This expansion is a strategic step in line with our long-term vision to strengthen our market position and fuel sustainable growth.”

The facility has been established with a total capital outlay of more than ₹ 450 crores and with the start of commercial production, the Company is poised to benefit from the Central Government's 'New Central Sector Scheme’, for Capital Interest Subvention of 6% per annum and GST-linked incentive of 300% of investment made in plant and machinery in 10 years.

No comments: